Samuel H. Selesnick, MD, has been selected as the new editor-in-chief of The Laryngoscope, an official journal of the Triological Society. He succeeds Michael G. Stewart, MD, who has served as the journal’s editor for eight years.
ENTtoday talked to Dr. Selesnick about his goals for the publication under his tenure.
ENTtoday: What is your background?
Dr. Selesnick: I went to medical school at NYU University School of Medicine, did my residency in otolaryngology at the Manhattan Eye, Ear, and Throat Hospital–Cornell Residency Program, and my fellowship in neurotology at the University of California in San Francisco. For the past 28 years, I’ve been on faculty at Weill Cornell Medical College where I am currently professor and vice chair of the department of otolaryngology, with appointments also in the departments of neurosurgery and neurology. I am also in the department of neurosurgery at Memorial Sloan Kettering Cancer Center.
I have served in a number of professional societies including as president of the American Neurotology Society, president of the American Neurological Society, member of the board of directors of the American Academy of Otolaryngology–Head and Neck Surgery and am currently general secretary of the International Society for Otologic Surgery and Science (Politzer Society).
ENTtoday: What do you see as the strengths of The Laryngoscope?
Dr. Selesnick: First, I am honored to be selected as the new editor-in-chief, and it is a challenge that I very much look forward to. The Laryngoscope is unique as the oldest journal in our field, dating back to the late 19th century. It has established itself as the primary voice for otolaryngologic clinical and translation research. We are fortunate to receive exceptional quality work and disseminate it widely. As the dominant journal in our field, we receive about 2,800 submissions a year. Also, we are very well read, with 70,000 downloads per month.
ENTtoday: What are your goals for the journal?
Dr. Selesnick: My goals are to both honor and maintain the heritage of the journal, yet embrace change. Science, clinical care, and medical publishing are all in an exciting time of rapid innovation. I plan to further streamline the submission and peer review process while maintaining the highest level of integrity in all processes of journal function. Ultimately, this will continue to provide the reader with exceptional quality clinical and translational research. Finally, The Laryngoscope closely shares its core values with The Triological Society and its other affiliated societies, the American Laryngological Association and the American Broncho-Esophagological Association.
I look forward to helping guide the journal forward, and hope that the journal will ultimately contribute to the improved care of the patients of our readers.